An in-depth look to SINPHAR PHARMACEUTICAL CO LTD operating, investing, and financing activities

1734 free cash flow for Q3 24 is 158.28 M TWD. For 2023, 1734 free cash flow was 1.26 M TWD and operating cash flow was 296.77 M TWD.